These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 28466142
1. Reappraisal of TDP-43 pathology in FTLD-U subtypes. Mackenzie IR, Neumann M. Acta Neuropathol; 2017 Jul; 134(1):79-96. PubMed ID: 28466142 [Abstract] [Full Text] [Related]
2. Subcortical TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases. Mackenzie IR, Neumann M. Acta Neuropathol; 2020 Jan; 139(1):83-98. PubMed ID: 31501924 [Abstract] [Full Text] [Related]
3. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Josephs KA, Stroh A, Dugger B, Dickson DW. Acta Neuropathol; 2009 Sep; 118(3):349-58. PubMed ID: 19455346 [Abstract] [Full Text] [Related]
4. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, Neary D, Snowden JS, Mann DM. Acta Neuropathol; 2007 May; 113(5):521-33. PubMed ID: 17219193 [Abstract] [Full Text] [Related]
9. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions. Josephs KA, Lin WL, Ahmed Z, Stroh DA, Graff-Radford NR, Dickson DW. Acta Neuropathol; 2008 Aug; 116(2):159-67. PubMed ID: 18553091 [Abstract] [Full Text] [Related]
10. TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing. Davidson Y, Amin H, Kelley T, Shi J, Tian J, Kumaran R, Lashley T, Lees AJ, DuPlessis D, Neary D, Snowden J, Akiyama H, Arai T, Hasegawa M, Bandopadhyay R, Sikkink S, Pickering-Brown S, Mann DM. Acta Neuropathol; 2009 Sep; 118(3):359-69. PubMed ID: 19330339 [Abstract] [Full Text] [Related]
11. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, Rogelj B, Al-Chalabi A, Hortobágyi T, Shaw CE. Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323 [Abstract] [Full Text] [Related]
12. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Roeber S, Mackenzie IR, Kretzschmar HA, Neumann M. Acta Neuropathol; 2008 Aug; 116(2):147-57. PubMed ID: 18536926 [Abstract] [Full Text] [Related]